Overview
In this Tech Talk, discover why now is the right time for a better model of drug-induced kidney injury and how EpiKidney, a human-relevant NAM, fills a critical gap in predicting kidney toxicity. We connect three converging themes—unmet patient need, regulatory momentum favoring NAMs, and enabling technologies like Incucyte live-cell kinetic analysis—to reveal a practical, scalable solution for modern kidney safety assessment.
Resource Details:
- Document Type: Tech Talk (Video Recording)
- Watch Time: 20 min
In this video recording, you will learn:
- Understand why current kidney toxicity models often fail in the clinic
- See how EpiKidney, a human-relevant NAM, improves prediction of drug-induced kidney injury
- Learn how Incucyte live-cell kinetic analysis enables sensitive, kinetic toxicity readouts
- Explore how unmet need, regulatory momentum, and enabling tech converge into a practical workflow